AZAD Pharma AG

Generic active pharmaceutical ingredients with proprietary synthesis routes and polymorphs, developed and managed by Schaffhausen chemists; including Bendamustine, Brinzolamide, Buprenorphine, Dorzolamide, Iron Sucrose, Paricalcitol, Sugammadex and Trandolapril.

Generic finished products, especially ophthalmics and parenterals, with unique formulations and CTD dossiers; including Brinzolamide, Latanoprost and Iron Sucrose products as well as other glaucoma and infusion preparations.

APIs in development, including Bilastine, Ferric Carboxymaltose, Nelarabine and Tafamidis; including process research, development of new polymorphs and patented chemical forms.

Finished products in development for glaucoma, in particular Brinzolamide-, Dorzolamide- and Bimatoprost combination products, preservative-free eye drops and microemulsions.